Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...
MANCHESTER, UK — There have been many recent advances in cardiac rhythm management, notably the use of leadless pacemakers and subcutaneous implantable cardioverter defibrillators (S-ICDs), experts ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...
Please provide your email address to receive an email when new articles are posted on . The first pacemaker implantation was performed in 1958, and the technology has undergone many advances since ...
An experimental, leadless pacemaker housing is able to partially recharge the device’s battery by generating electrical energy from heartbeats. The device generated about 10% of the energy needed to ...
Patients with intracardiac shunts might at some point require a pacemaker or an implantable cardioverter–defibrillator (ICD). These patients may have numerous thrombotic risk factors, however, and ...
Please provide your email address to receive an email when new articles are posted on . “Prior research has established the subcutaneous ICD as a reasonable alternative to the transvenous ICD in ...
Mechanical and electrical energy are linked and can be exchanged back and forth. Just like ultrasound converts electrical voltage into pressure or sound, we can engineer similar materials onto ...
Photo Credit: Adapted from Brown K. TCT 564: A new perspective: intracardiac echocardiographic guidance for the implantation of a left atrial appendage occluder device (Watchman) with a leadless ...
There are unique technical issues that must be considered with the implantation of devices in small patients and those with CHD. Although most centers report low complication rates of complications in ...